| Identification | Back Directory | [Name]
2-Propenamide, N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-[1-(methyl-d3)-1H-indol-3-yl]-2-pyrimidinyl]amino]phenyl]- | [CAS]
1638281-46-5 | [Synonyms]
Asandeutertinib/asandeutertinibum/Osimertinib-d3/AZD-9291-d3
2-Propenamide, N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-[1-(methyl-d3)-1H-indol-3-yl]-2-pyrimidinyl]amino]phenyl]- | [Molecular Formula]
C28H33N7O2 | [MOL File]
1638281-46-5.mol | [Molecular Weight]
499.62 |
| Hazard Information | Back Directory | [Uses]
Asandeutertinib (Osimertinib-d3; AZD-9291-d3) is a epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, with antineoplastic effect[1]. | [References]
[1] Asandeutertinib (asandeutertinibum; Osimertinib-d3; AZD-9291-d3). WHO Drug Information, Vol. 37, No. 4, 2023. |
|
|